Analyzing the Impact of Exposure to Antibiotics on Immune Checkpoint Inhibitor Efficacy: Stop at a Methodological Checkpoint

J Clin Oncol. 2023 Nov 10;41(32):5072-5073. doi: 10.1200/JCO.23.00730. Epub 2023 Aug 23.

Authors

Florence Poizeau, Alain Dupuy¹

Affiliation

¹ Florence Poizeau, MD, PhD and Alain Dupuy, MD, PhD, Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement etTravail)-UMR_S 1085, Rennes, France; Department of Dermatology, Univ Rennes, CHU Rennes, Rennes, France.

PMID: 37611217
DOI: 10.1200/JCO.23.00730

No abstract available

Publication types

Letter

MeSH terms

Anti-Bacterial Agents / adverse effects
Antineoplastic Agents, Immunological* / adverse effects
Humans
Immune Checkpoint Inhibitors*
Immunotherapy

Substances

Immune Checkpoint Inhibitors
Anti-Bacterial Agents
Antineoplastic Agents, Immunological